StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
OSRH

OSR Health, Inc.

OSRH Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗
$0.45
+0.02 +3.72%

Key statistics

from XBRL data in SEC filings
Market cap
$15.7M
Revenue (TTM)
$2.63M
Net income (TTM)
-$19.1M
EPS (TTM)
$0.16
P/E ratio
2.8
Dividend yield
Free cash flow
Cash
$1.57M
Total assets
$172M
Gross margin
22.2%
52-week range
$0.30 – $1.24

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Regulation FD disclosure Jul 31, 2026 8-K Amended charter or bylaws Jun 17, 2026 8-K Other events Jun 11, 2026 8-K Entered a material agreement Jun 2, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K/A AMENDMENT NO. 1 TO FORM 8-K May 6, 2026 8-K Entered a material agreement; Regulation FD disclosure Apr 30, 2026 8-K Director or officer change Apr 22, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Apr 9, 2026 8-K/A AMENDMENT NO. 1 TO FORM 8-K Apr 3, 2026 8-K Entered a material agreement Apr 2, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Regulation FD disclosure Mar 16, 2026 8-K Delisting notice or listing-rule failure Mar 10, 2026 8-K Completed an acquisition or disposition; Regulation FD disclosure Jan 27, 2026 8-K Entered a material agreement; Regulation FD disclosure Jan 14, 2026 8-K Regulation FD disclosure; Other events Nov 25, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Entered a material agreement; Regulation FD disclosure Oct 16, 2025 8-K Shareholder vote results Sep 23, 2025 8-K Delisting notice or listing-rule failure Sep 9, 2025 8-K Other events Sep 9, 2025 8-K Entered a material agreement Aug 20, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Regulation FD disclosure Aug 6, 2025 8-K Other events Jul 25, 2025 8-K Director or officer change Jul 2, 2025 10-Q Quarter ended 2025-03-31 May 20, 2025 8-K Entered a material agreement May 12, 2025 8-K/A AMENDMENT NO. 1 TO FORM 8-K Apr 22, 2025 10-K Fiscal year ended 2024-12-31 Apr 22, 2025 8-K Director or officer change Mar 25, 2025 8-K Entered a material agreement; Unregistered sale of equity Feb 28, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Modified rights of security holders; Change in control; Director or officer change; Amended charter or bylaws; Item 5.06 Feb 21, 2025 8-K Other events Feb 18, 2025 8-K Amended charter or bylaws; Shareholder vote results; Other events Feb 13, 2025 8-K Entered a material agreement; Took on a direct financial obligation Jan 23, 2025 8-K Entered a material agreement; Took on a direct financial obligation Jan 10, 2025 8-K Entered a material agreement Dec 23, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024